Montecalvo Antonio S. 4

What Happened

• Antonio S. Montecalvo, Vice President, Health Policy at Organogenesis (ORGO), disposed of a total of 18,619 shares on Feb 15, 2026 to satisfy tax obligations. The disposals were recorded as payments of exercise price or tax liability (transaction code F).
• The four withheld/surrendered lots were: 1,389 shares ($5,181), 9,607 shares ($35,834), 4,100 shares ($15,293), and 3,523 shares ($13,141), all at $3.73 per share, for an aggregate value of approximately $69,449.
• This was a tax-withholding/share-surrender action (common after option exercises or vesting), not an open-market sale intended to realize cash proceeds.

Key Details

• Transaction date: February 15, 2026; Filing date: February 18, 2026 (filed within the standard 2 business-day window).
• Price per share: $3.73; Total shares surrendered: 18,619; Total value ≈ $69,449.
• Transaction code: F — Payment of exercise price or tax liability (shares were surrendered/disposed to cover taxes).
• Shares owned after the transaction: not provided in the details supplied here — see the Form 4 filing for exact post-transaction holdings.
• No indication in the supplied data of a 10b5-1 plan or other special arrangement.

Context

• When insiders "dispose" shares under code F it typically means shares were withheld or surrendered to cover taxes following an option exercise or restricted stock vesting. Those shares are not necessarily sold on the open market, so this is generally viewed as routine tax-related withholding rather than a directional bet on the stock.
• For retail investors, outright purchases by insiders can be a stronger signal; tax-withholding disposals are common and do not necessarily reflect the insider’s view of the company’s prospects.